{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:44:34Z","timestamp":1792601074888,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,20]]},"abstract":"<jats:p>\n                    The association between glucagon-like peptide-1 receptor agonists (GLP-1RAs) and gastrointestinal events remains controversial in observational studies. To address this, our study employed drug-target Mendelian randomization (MR) to investigate the causal relationship between GLP-1RAs and 24 gastrointestinal disorders, supplemented by sensitivity analyses, Cox proportional hazards regression analysis and mediation testing. Using single-nucleotide polymorphisms significantly associated with GLP1R gene expression as instrumental variables, we mimicked the lifelong pharmacological effects of GLP-1RAs. The significant causal association was further examined by the association study using weighted polygenic scores (PGSs) for GLP1R expression by the Cox proportional hazards regression model in UK Biobank (UKB). Our results revealed that genetically proxied GLP-1RA effects were significantly associated with a lower risk of paralytic ileus (log(OR)\u2005=\u2005\u22121.474, 95% CI = (\u22122.164, \u22120.784),\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u20052.86\u2005\u00d7\u200510\n                    <jats:sup>\u22125<\/jats:sup>\n                    ). The direction of the association was further supported by Cox proportional hazards model using PGSs in the UKB, though the association did not reach significance (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u2005.05). According to two-step mediation analysis, glycated hemoglobin A1c and body mass index only mediated 1.58% and 0.52% of the protective effect of GLP-1RAs on paralytic ileus. Unlike observational studies, our MR analysis found no causal links between GLP-1R expression and the other gastrointestinal events including cholelithiasis, pancreatitis and so on. By overcoming confounding biases inherent in observational research, this study provides genetic evidence supporting the causal protective effect of GLP-1 receptor agonists on paralytic ileus and highlights the need to reevaluate GLP-1RA-associated gastrointestinal risks in clinical contexts.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000048089","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:00:40Z","timestamp":1774036840000},"page":"e48089","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Genetic evidence for a causal protective effect of GLP-1 receptor agonists on paralytic ileus but not on other gastrointestinal events"],"prefix":"10.1097","volume":"105","author":[{"given":"Bo","family":"Yuan","sequence":"first","affiliation":[{"name":"Shanghai Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Yang","sequence":"additional","affiliation":[{"name":"Shanghai Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenmiao","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Zong","sequence":"additional","affiliation":[{"name":"Institute of Nutrition, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Information, Changhai Hospital, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengwu","family":"Feng","sequence":"additional","affiliation":[{"name":"CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7429-4706","authenticated-orcid":false,"given":"Xin","family":"Geng","sequence":"additional","affiliation":[{"name":"Shanghai Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China"},{"name":"National Center for Liver Cancer, Naval Medical University, Shanghai, China"},{"name":"Ministry of Education Key Laboratory on Signaling Regulation and Targeting Therapy of Liver Cancer, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260422","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41591-025-03542-9","article-title":"Mapping the effectiveness and risks of GLP-1 receptor agonists.","volume":"31","author":"Xie","year":"2025","journal-title":"Nat Med"},{"key":"R2-20260422","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1001\/jama.2023.19574","article-title":"Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss.","volume":"330","author":"Sodhi","year":"2023","journal-title":"JAMA"},{"key":"R3-20260422","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2337\/dc16-0984","article-title":"Assessment of pancreas safety in the development program of once-weekly GLP-1 receptor agonist dulaglutide.","volume":"40","author":"Nauck","year":"2017","journal-title":"Diabetes Care"},{"key":"R5-20260422","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/jamainternmed.2016.1522","article-title":"Association between incretin-based drugs and the risk of acute pancreatitis.","volume":"176","author":"Azoulay","year":"2016","journal-title":"JAMA Intern Med"},{"key":"R6-20260422","doi-asserted-by":"crossref","first-page":"g2366","DOI":"10.1136\/bmj.g2366","article-title":"Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies.","volume":"348","author":"Li","year":"2014","journal-title":"BMJ"},{"key":"R7-20260422","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jamainternmed.2022.0338","article-title":"Association of glucagon-like peptide-1 receptor agonist use with risk of gallbladder and biliary diseases: a systematic review and meta-analysis of randomized clinical trials.","volume":"182","author":"He","year":"2022","journal-title":"JAMA Intern Med"},{"key":"R8-20260422","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1053\/j.gastro.2025.06.003","article-title":"Glucagon-like peptide-1 receptor agonists and gastrointestinal adverse events: a systematic review and meta-analysis.","volume":"169","author":"Chiang","year":"2025","journal-title":"Gastroenterology"},{"key":"R9-20260422","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/ije\/dyv108","article-title":"Mendelian randomization: where are we now and where are we going?","volume":"44","author":"Burgess","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R10-20260422","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/jbmr.4880","article-title":"Evaluation of the effect of sodium\u2010glucose cotransporter 2 inhibition on fracture risk: evidence from mendelian randomization and genetic association study.","volume":"38","author":"Dai","year":"2023","journal-title":"J Bone Miner Res"},{"key":"R11-20260422","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","article-title":"Large-scale cis-and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression.","volume":"53","author":"V\u00f5sa","year":"2021","journal-title":"Nat Genet"},{"key":"R12-20260422","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1111\/dom.16489","article-title":"GLP\u20101 receptor agonists and the risk for cancer: a meta\u2010analysis of randomized controlled trials.","volume":"27","author":"Silverii","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"R13-20260422","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ije\/dyt179","article-title":"Calculating statistical power in Mendelian randomization studies.","volume":"42","author":"Brion","year":"2013","journal-title":"Int J Epidemiol"},{"key":"R14-20260422","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data.","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"R15-20260422","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/CIRCULATIONAHA.115.018585","article-title":"Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review.","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"R16-20260422","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1001\/jama.2018.14854","article-title":"The physical activity guidelines for Americans.","volume":"320","author":"Piercy","year":"2018","journal-title":"JAMA"},{"key":"R17-20260422","article-title":"GLP-1 receptor agonists and risk of paralytic ileus: a drug-target mendelian randomization study.","author":"Ding","year":"2024","journal-title":"medRxiv"},{"key":"R18-20260422","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrendo.2009.213","article-title":"Residual microvascular risk in diabetes: unmet needs and future directions.","volume":"6","author":"Fioretto","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"R19-20260422","doi-asserted-by":"crossref","first-page":"106320","DOI":"10.1016\/j.phrs.2022.106320","article-title":"The anti-inflammatory and immunological properties of GLP-1 receptor agonists.","volume":"182","author":"Bendotti","year":"2022","journal-title":"Pharmacol Res"},{"key":"R20-20260422","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/j.1476-5381.2012.01971.x","article-title":"Neuroprotective and neurotrophic actions of glucagon\u2010like peptide\u20101: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders.","volume":"166","author":"Salcedo","year":"2012","journal-title":"Br J Pharmacol"},{"key":"R21-20260422","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41572-019-0092-1","article-title":"Diabetic neuropathy.","volume":"5","author":"Feldman","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"R22-20260422","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.urology.2010.02.053","article-title":"Age and body mass index are independent risk factors for the development of postoperative paralytic ileus after radical cystectomy.","volume":"76","author":"Svatek","year":"2010","journal-title":"Urology"},{"key":"R23-20260422","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/cpt.2430","article-title":"Incretin\u2010based drugs and risk of intestinal obstruction among patients with type 2 diabetes.","volume":"111","author":"Faillie","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"R24-20260422","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.cgh.2023.08.034","article-title":"Use of DPP4 inhibitors and GLP-1 receptor agonists and risk of intestinal obstruction: scandinavian cohort study.","volume":"22","author":"Ueda","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R25-20260422","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s00592-025-02525-z","article-title":"Association of GLP-1 receptor agonists with risk of intestinal obstruction in patients with type 2 diabetes mellitus: a retrospective cohort study.","volume":"62","author":"Gao","year":"2025","journal-title":"Acta Diabetol"},{"key":"R26-20260422","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41591-024-03412-w","article-title":"Mapping the effectiveness and risks of GLP-1 receptor agonists.","volume":"31","author":"Xie","year":"2025","journal-title":"Nat Med"},{"key":"R27-20260422","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1038\/s41591-025-03799-0","article-title":"Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis.","volume":"31","author":"Jara","year":"2025","journal-title":"Nat Med"},{"key":"R28-20260422","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.7326\/0003-4819-119-10-199311150-00010","article-title":"Contributions of obesity and weight loss to gallstone disease.","volume":"119","author":"Everhart","year":"1993","journal-title":"Ann Intern Med"},{"key":"R29-20260422","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/gutjnl-2024-332254","article-title":"Genetic evidence for repurposing of glucagon-like peptide-1 receptor agonists to prevent chronic liver diseases.","volume":"73","author":"Liu","year":"2024","journal-title":"Gut"},{"key":"R30-20260422","doi-asserted-by":"crossref","first-page":"111882","DOI":"10.1016\/j.diabres.2024.111882","article-title":"Hypoglycemic drugs, circulating inflammatory proteins, and gallbladder diseases: a mediation mendelian randomization study.","volume":"217","author":"Wang","year":"2024","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:56:53Z","timestamp":1786035413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048089","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"2026-01-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}